Opening Improving Diagnostic Accuracy in Parkinson's Disease by Victoria Holiday, MD
Improving Diagnostic Accuracy in Parkinson's Disease by Victoria Holiday, MD
- Length
- 1 h 4 min
- Level
- Undergraduate
- Recorded
- University of Louisville2022
Chapter 1 of 10: Before the lecture
Reviews diagnostic testing for Parkinson's disease, evaluating skin biopsies and MIBG scans against clinical cases.
Parkinson's disease diagnostic accuracy involves evaluating clinical presentations against available biomarker tests and genetic panels. Victoria Holiday reviews the diagnostic utility of treatment trials, olfactory testing, DaT-SPECT, skin biopsies for phosphorylated alpha-synuclein, MIBG-SPECT, and brain MRI indices. Three patient cases illustrate the challenges of differentiating idiopathic Parkinson's disease from atypical parkinsonian syndromes such as progressive supranuclear palsy and multiple system atrophy. The seminar concludes with a discussion of hereditary panels and the prognostic implications of GBA mutations.
Parkinson's disease diagnostic accuracy involves evaluating clinical presentations against available biomarker tests and genetic panels. Victoria Holiday reviews the diagnostic utility of treatment trials, olfactory testing, DaT-SPECT, skin biopsies for phosphorylated alpha-synuclein, MIBG-SPECT, and brain MRI indices. Three patient cases illustrate the challenges of differentiating idiopathic Parkinson's disease from atypical parkinsonian syndromes such as progressive supranuclear palsy and multiple system atrophy. The seminar concludes with a discussion of hereditary panels and the prognostic implications of GBA mutations.
Study on challenging tremor-predominant PD patients with levodopa
Krismer et al. study on olfaction in PD, MSA, and PSP
Skin Biopsy May Help to Distinguish Multiple System Atrophy-Parkinsonism From Parkinson's Disease With Orthostatic Hypotension
Presence of Skin $\alpha$-Synuclein Deposits Discriminates Parkinson's Disease from Progressive Supranuclear Palsy and Corticobasal Syndrome
GBA-associated Parkinson's Disease: Reduced survival and rapid progression in a prospective longitudinal study

This lecture
Talk 61 of 115 of UofL Neurology Grand Rounds.
Choose a node to see how it connects to this lecture. What comes before is on the leftat the top. What comes after is on the rightat the bottom. The ring is what it teaches. People and places are above. Other lectures and books are below.
Press a chosen node again to open it.
Your comment is kept while you sign up.Sign in
Syn-One-Slice skin biopsy detection of phosphorylated alpha-synuclein for diagnosis of synucleinopathies
Sensitivity and specificity of cardiac 123I-MIBG scintigraphy for the diagnosis of early-phase Parkinson's disease
Sniffing the diagnosis: Olfactory testing in neurodegenerative parkinsonism
Olfactory Testing in Parkinson Disease and REM Behavior Disorder
Association of GBA Genotype with Motor and Functional Decline in Patient's with Newly Diagnosed Parkinson Disease
Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease
The diagnostic accuracy of the hummingbird and morning glory signs in patients with neurodegenerative parkinsonism
Cardiac 123I-MIBG Scintigraphy in Neurodegenerative Parkinsonism Syndromes: Performance and Profiles in Clinical Practice
Challenges in the diagnosis of Parkinson's disease
Dopamine-responsive and dopamine-resistant resting tremor in Parkinson disease
Synuclein-one skin biopsy detection of phosphorylated alpha-synuclein for diagnosis of synucleinopathies
Cardiac 123I-MIBG scintigraphy in Diagnostic Neurodegenerative Parkinson Syndromes: Performance and Pitfalls in Clinical Practice